← Back to Clinical Trials
Recruiting NCT05281016

NCT05281016 Integrating Community LITE Programme as an Online Family-based Intervention to Combat Childhood Obesity

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05281016
Status Recruiting
Phase
Sponsor KK Women's and Children's Hospital
Condition Pediatric Obesity
Study Type INTERVENTIONAL
Enrollment 100 participants
Start Date 2022-04-22
Primary Completion 2025-12

Eligibility & Interventions

Sex All sexes
Min Age 6 Years
Max Age 12 Years
Study Type INTERVENTIONAL
Interventions
Usual CareOnline community LITE programme

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 100 participants in total. It began in 2022-04-22 with a primary completion date of 2025-12.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Childhood obesity in Singapore is rising with a record prevalence of 13% in 2017 (1). Given that 70% of overweight children remain so into adulthood (2), this will further increase the public health epidemic of diabetes among Singaporeans. Early intervention is thus critical to improve the weight trajectory of overweight children and foster life long healthy lifestyle habits. Family-based interventions combining dietary, physical activity and behavioural interventions are currently recommended as the best practice in the management of childhood obesity in children younger than 12 years old (3-7). Our pilot study on family-based intervention in the tertiary setting demonstrated feasibility and short-term effectiveness. However, its outreach and sustainable results are limited. Currently, school-based screening, weight management clinics and community recreational facilities are operating in silos with limited effectiveness. Here, the investigators will integrate our family-based intervention into a school, clinic and community partnership to achieve an impactful and sustainable outcome for families with overweight children. The community Lifestyle InTervention for Everyone (LITE) program is a structured, group family-based multicomponent lifestyle intervention. Community LITE program will introduce various exercise programs within the family based online sessions to reduce perceived barrier and promote self-efficacy of community sports facilities to increase physical activity. Children have minimal control over their food and physical activity choices especially in current obesogenic environment (8). Parents are the most important influencers(9) to impose interventions for childhood obesity through parental practices and parenting style(10). Therefore, they are the main focus of the community-based intervention program.

Eligibility Criteria

Inclusion Criteria: * Overweight as defined by BMI percentile of above 90th percentile * Age 6- 12 years old * Ability to provide informed consent Exclusion Criteria: * Patients with secondary causes of obesity especially genetic syndromes e.g. Trisomy 21, Prader-Willi, and those who are taking medications that can affect weight status. * Intellectual disability, poor level of spoken English (including their parent/carer) * Significant medical illness that precludes physical activity and significant psychiatric illness * Sibling who is already participating in the study

Contact & Investigator

Central Contact

Khairunisa Bte Khaider

✉ khairunisa.khaider@kkh.com.sg

📞 +6581986365

Principal Investigator

Elaine Chu Shan Chew, MBBS

PRINCIPAL INVESTIGATOR

KK Women's and Children's Hospital

Frequently Asked Questions

Who can join the NCT05281016 clinical trial?

This trial is open to participants of all sexes, aged 6 Years or older, up to 12 Years, studying Pediatric Obesity. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT05281016 currently recruiting?

Yes, NCT05281016 is actively recruiting participants. Contact the research team at khairunisa.khaider@kkh.com.sg for enrollment information.

Where is the NCT05281016 trial being conducted?

This trial is being conducted at Singapore, Singapore.

Who is sponsoring the NCT05281016 clinical trial?

NCT05281016 is sponsored by KK Women's and Children's Hospital. The principal investigator is Elaine Chu Shan Chew, MBBS at KK Women's and Children's Hospital. The trial plans to enroll 100 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology